SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):September 15, 2014
|
MERIDIAN BIOSCIENCE, INC.
|
|
(Exact name of registrant as specified in its charter)
|
|
Ohio
|
0-14902
|
31-0888197
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No. )
|
|
3471 River Hills Drive, Cincinnati, Ohio
|
45244
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code(513) 271-3700
|
|
|
|
|
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
___ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
___ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
___ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01. Other Events.
The Board of Directors of Meridian Bioscience, Inc. sadly announces the passing of its founder and Executive Chairman of the Board, William J. Motto. In a special meeting held today, September 15, 2014, the Board of Directors elected John A. Kraeutler as its Chairman. Mr. Kraeutler will now hold the positions of Chairman and Chief Executive Officer.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MERIDIAN BIOSCIENCE, INC.
Melissa A. Lueke
Executive Vice President and
Chief Financial Officer
Chief Financial Officer
(Principal Financial and Accounting Officer)